Literature DB >> 3415965

Ethinylestradiol administration selectively alters liver sinusoidal membrane lipid fluidity and protein composition.

J Rosario1, E Sutherland, L Zaccaro, F R Simon.   

Abstract

Administration of high-dose ethinylestradiol to rats decreases bile flow, Na,K-ATPase specific activity, and liver plasma membrane fluidity. By use of highly purified sinusoidal and bile canalicular membrane fractions, the effect of ethinylestradiol administration on the protein and lipid composition and fluidity of plasma membrane fractions was examined. In sinusoidal fractions, ethinylestradiol (EE) administration decreased Na,K-ATPase activity (32%) and increased activities of alkaline phosphatase (254%), Mg2+-ATPase (155%), and a 160-kDa polypeptide (10-fold). Steady-state and dynamic fluorescence polarization was used to study membrane lipid structure. Steady-state polarization of diphenylhexatriene (DPH) was significantly higher in canalicular compared to sinusoidal membrane fractions. Ethinylestradiol (5 mg/kg per day for 5 days) selectively increased sinusoidal polarization values. Similar changes were demonstrated with the probes 2- and 12-anthroyloxystearate. Time-resolved fluorescence polarization measurements indicated that EE administration for 5 days did not change DPH lifetime but increased the order component (r infinity) and decreased the rotation rate (R). However, 1 and 3 days after EE administration and with low doses (10-100 micrograms/kg per day for 5 days) the Na,K-ATPase, bile flow, and order component were altered, but the rotation rate was unchanged. Vesicles prepared from total sinusoidal membrane lipids of EE-treated rats, as well as phospholipid vesicles, demonstrated increased DPH polarization, as did intact plasma membrane fractions. Liver plasma membrane fractions showed no change in free cholesterol or cholesterol/phospholipid molar ratio, while esterified cholesterol content was increased with high-dose but not low-dose ethinylestradiol.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3415965     DOI: 10.1021/bi00411a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Biochemical localization of hepatic surface-membrane Na+,K+-ATPase activity depends on membrane lipid fluidity.

Authors:  E Sutherland; B S Dixon; H L Leffert; H Skally; L Zaccaro; F R Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

2.  Hepatic immunohistochemical localization of the tight junction protein ZO-1 in rat models of cholestasis.

Authors:  J M Anderson; J L Glade; B R Stevenson; J L Boyer; M S Mooseker
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

3.  ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy.

Authors:  R Müllenbach; A Bennett; N Tetlow; N Patel; G Hamilton; F Cheng; J Chambers; R Howard; S D Taylor-Robinson; C Williamson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 4.  Cellular mechanisms of intrahepatic cholestasis.

Authors:  P J Meier-Abt
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 5.  Mechanisms and functional features of polarized membrane traffic in epithelial and hepatic cells.

Authors:  M M Zegers; D Hoekstra
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

6.  Protective effect of Jasonia montana against ethinylestradiol-induced cholestasis in rats.

Authors:  Mohammed A Hussein; Soad M Abdel-Gawad
Journal:  Saudi Pharm J       Date:  2009-12-23       Impact factor: 4.330

7.  Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver.

Authors:  R Bossard; B Stieger; B O'Neill; G Fricker; P J Meier
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

8.  Changes in GM1 ganglioside content and localization in cholestatic rat liver.

Authors:  Marie Jirkovská; Filip Majer; Jaroslava Smídová; Jan Stríteský; Gouse Mohiddin Shaik; Petr Dráber; Libor Vítek; Zdenek Marecek; Frantisek Smíd
Journal:  Glycoconj J       Date:  2007-02-27       Impact factor: 3.009

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.